Kondo, K., Shimizu, H., Kako, S., Tachibana, T., Izumi, A., Tanoue, S., Sakaida, E., Shono, K., Fukuda, T., Najima, Y., Shindo, T., Sakurai, M., Kimura, S., Tanaka, M., Tsukamoto, S., Naganuma, K., Tabayashi, T., Machida, S., Onizuka, M., Takada, S., Fujisawa, S., Kataoka, K., Doki, N., Kanda, Y. (2025). Nelarabine treatment before allogeneic stem cell transplantation was associated with an increased risk of neurological adverse events in patients with T-ALL/lbl: A retrospective study of the kanto study group for cell therapy.. Blood. https://doi.org/10.1182/blood-2025-6043